Secular trends of blood isolates in patients from a rural area population hospitalized in a tertiary center in a small city in Greece

BMC Microbiology

Volumn 6, Issue , 2006, Pages

  Falagas, Matthew E ^a,b   Bakossi, Alexandra ^c   Pappas, Vasilis D ^a   Holevas, Pierros V ^c   Bouras, Antonis ^c   Stamata, Eleni ^c  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c General Hospital of Tripolis   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; OXACILLIN; PENICILLIN G; SULFAMETHOXAZOLE; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BLOOD CULTURE; BLOOD SAMPLING; CANDIDA; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GREECE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; RURAL AREA; RURAL POPULATION; STAPHYLOCOCCUS AUREUS; TERTIARY HEALTH CARE;

BACTEREMIA; DRUG RESISTANCE, BACTERIAL; GREECE; HOSPITALIZATION; HOSPITALS, RURAL; HUMANS; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES;

ACINETOBACTER; ESCHERICHIA COLI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 33646550883     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-6-41     Document Type: Article

References (21)

1. Kapil A: The challenge of antibiotic resistance: need to contemplate. Indian J Med Res 2005, 121:83-91.
2. Ansari MZ, Collopy BT: Nosocomial infection indicators in Australian hospitals: assessment according to hospital characteristics. J Qual Clin Pract 1997, 17:73-82.
3. Elhanan G, Raz R, Pitlik SD, Sharir R, Konisberger H, Samra Z, Kennes Y, Drucker M, Leibovici L: Bacteremia in a community and a university hospital. J Antimicrob Chemother 1995, 36:681-95.
4. McLaws ML, Gold J, King K, Irwig LM, Berry G: The prevalence of nosocomial and community-acquired infections in Australian hospitals. Med J Aust 1998, 149:582-90.
5. Carroll KC, Monroe P, Cohen S, Hoffman M, Hamilton L, Korgenski K, Reimer L, Classen D, Daly J: Susceptibility of beta-hemolytic streptococci to nine antimicrobial agents among four medical centers in Salt Lake City, Utah, USA. Diagn Microbiol Infect Dis 1997, 27:123-8.
6. Parry MF: Epidemiology and mechanisms of antimicrobial resistance. Am J Infect Control 1989, 17:286-94.
7. Madsen KM, Schonheyder HC, Kristensen B, Sorensen HT: Secular trends in incidence and mortality of bacteremia in a Danish county 1981-1994. APMIS 1999, 107:346-52.
8. Hadziyannis AS, Stephanou I, Dimarogona K, Pantazatou A, Fourkas D, Filiagouridis D, Avlami A: Blood culture results during the period 1995-2002 in a Greek tertiary care hospital. Clin Microbiol Infect 2004, 10:667-70.
9. Gross PA, Barrett TL, Dellinger EP, Krause PJ, Martone WJ, McGowan JE Jr, Sweet RL, Wenzel RP: Quality standard for the treatment of bacteremia. Infectious Diseases Society of America. Clin Infect Dis 1994, 18:428-30.
10. Lyytikainen O, Lumio J, Sarkinnen H, Kolho E, Kostiala A, Ruutu P: Nosocomial bloodstream infections in Finnish hospitals during 1999-2000. Clin Infect Dis 2002, 35:14-9.
11. Zinner SH: Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis 1999, 29:490-4.
12. Bansal S, Jain A, Agarwal J, Malik GK: Significance of coagulase negative staphylococci in neonates with late onset septicemia. Indian J Pathol Microbiol 2004, 47:586-8.
13. Favre B, Hugonnet S, Correa L, Sax H, Rohner P, Pittet D: Nosocomial bacteremia: clinical significance of a single blood culture positive for coagulase-negative staphylococci. Infect Control Hosp Epidemiol 2005, 26:697-702.
14. Lopez Dupla M, Martinez JA, Vidal F, Almela M, Lopez J, Marco F, Soriano A, Richart C, Mensa J: Clinical characterization of breakthrough bacteremia: a survey of 392 episodes. J Intern Med 2005, 258:172-80.
15. Beekmann SE, Diekema DJ, Doern GV: Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures. Infect Control Hosp Epidemiol 2005, 26:559-66.
16. Abelson JA, Moore T, Bruckner D, Deville J, Nielsen K: Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution. Pediatrics 2005, 116:61-7.
17. Chen YC, Chang SC, Sun CC, Yang LS, Hsieh WC, Luh KT: Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol 1997, 18:369-75.
18. Navon-Venezia S, Ben-Ami R, Carmeli Y: Update on Pseudomonas aeruginosa and Acinetobacter baumanii infections in the healthcare setting. Curr Opin Infect Dis 2005, 18:306-13.
19. Rossolini GM, Mantengoli E: Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 2005, 4:17-32.
20. Jain R, Danziger LH: Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. Ann Pharmacotherap 2004, 38:1449-59.
21. Rafailidis P, Kasiakou SK, Morfou P, Georgoulias G, Nikita D, Falagas M: Secular trends of antimicrobial resistance of blood isolates in a newly founded Greek hospital. In 16th European Conference of Clinical Microbiology and Infectious Diseases (ECCMID): 1-4 April 2006 Nice, France.